ClearPoint Neuro, Inc. (CLPT) vs Embecta Corp. (EMBC)
A side-by-side comparison of ClearPoint Neuro, Inc. and Embecta Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CLPT
ClearPoint Neuro, Inc.
$11.52HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
EMBC
Embecta Corp.
$5.88HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — CLPT vs EMBC
growth of $100 · dividends reinvested · last 5yCLPT +21.6% (+4.0%/yr)EMBC -85.5% (-32.1%/yr)CLPT compounded faster over this window
Log scale — wide-divergence pair
CLPT EMBC
CLPT vs EMBC: by the numbers
- •EMBC is the larger company ($349M vs $345M market cap).
- •EMBC is profitable (8.59% net margin) while CLPT runs a net loss (-81.76%).
- •CLPT grew revenue faster over the past five years (23.57% vs -0.09% CAGR).
- •EMBC pays a dividend (5.44% yield), while CLPT has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | CLPT | EMBC |
|---|---|---|
| P/E ratio | N/A | 3.97 |
| Forward P/E | N/A | 3.34 |
| P/S ratio | 8.17 | 0.34 |
| P/B ratio | 32.06 | N/A |
| EV / EBITDA | N/A | 5.36 |
| FCF yield | N/A | 47.18% |
Profitability
| Metric | CLPT | EMBC |
|---|---|---|
| Gross margin | 62.61% | 59.89% |
| Operating margin | -65.36% | 24.85% |
| Net margin | -81.76% | 8.59% |
| ROE | -320.77% | N/A |
| ROIC | -40.51% | 17.99% |
Dividends
| Metric | CLPT | EMBC |
|---|---|---|
| Dividend yield | N/A | 5.44% |
| Payout ratio | N/A | 21.62% |
Growth (annualized)
| Metric | CLPT | EMBC |
|---|---|---|
| Revenue CAGR (5Y) | 23.57% | -0.09% |
| EPS CAGR (5Y) | N/A | -26.22% |
| FCF CAGR (5Y) | N/A | -16.77% |
| Total return CAGR (5Y) | -7.65% | N/A |
Frequently asked
- Which has grown faster, CLPT or EMBC?
- Over the past five years, CLPT grew revenue faster — CLPT at a 23.57% CAGR versus EMBC at -0.09%.
- Does CLPT or EMBC pay a bigger dividend?
- EMBC pays a dividend (5.44% yield), while CLPT has no payments in the available dividend history.
- Is CLPT or EMBC more profitable?
- EMBC runs the higher net margin — CLPT at -81.76% versus EMBC at 8.59%.
Go deeper
Dig into the metrics
Embecta P/E ratioEmbecta dividend yieldClearPoint Neuro ROEEmbecta ROEClearPoint Neuro operating marginEmbecta operating marginClearPoint Neuro revenue growthEmbecta revenue growthClearPoint Neuro free cash flowEmbecta free cash flow
ClearPoint Neuro & Embecta appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.